Design of debunking the frailty-sarcopenia-ADT axis in metastatic prostate cancer with multicomponent exercise: the FIERCE trial protocol.
Rebekah L Wilson, Anderson Vulczak, Alicia K Morgans...
https://pubmed.ncbi.nlm.nih.gov/41210271/Actively Recruiting
Led by University of Alicante · Updated on 2026-05-07
66
Participants Needed
1
Research Sites
4 weeks
Total Duration
Researchers are investigating whether a low to moderate load power training program can improve fitness and quality of life for men with metastatic prostate cancer receiving androgen deprivation therapy ADT. This trial focuses on men experiencing bone or lymph node metastases, exploring how power training affects physical side effects like muscle strength, endurance, balance, and mental health. The study also seeks to understand participant experiences through interviews, combining quantitative and qualitative methods for a comprehensive view. Participants are randomly assigned to either a supervised power-oriented resistance training group or a control group receiving usual care with physical activity guidance. The exercise program involves two sessions per week over 24 weeks, emphasizing rapid muscle force production at moderate intensity 40-50% 1RM with low to moderate volume and no training to failure. The control group continues routine care with advice on strength training at home. During the study, participants will complete fitness tests and questionnaires assessing quality of life, mental health, functional capacity, and physical activity levels over six months. Those in the exercise group will also take part in semi-structured interviews to explore psychosocial impacts. Researchers will monitor adverse events and evaluate outcomes such as health-related quality of life, muscle strength, balance, gait speed, and mental health. The total study duration includes the 24-week intervention and a follow-up period to assess lasting effects.
CONDITIONS
Low to Moderate Load Power Training for Men With Metastatic Prostate Cancer.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Alicante
Lead Sponsor
Hospital General Universitario Dr. Balmis de Alicante
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 24 weeks
Participants in the power training group attend supervised power-oriented resistance training sessions twice per week for 24 weeks, focusing on improving muscle power with moderate intensity exercises. Participants in the control group receive information and guidance on physical activity to perform at home.
2 sessions per week
Duration - 6 months
Participants are monitored for an additional 6 months after the exercise program to assess lasting effects on quality of life, functional capacity, and mental health.
Visits scheduled as per study protocol
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Rebekah L Wilson, Anderson Vulczak, Alicia K Morgans...
https://pubmed.ncbi.nlm.nih.gov/41210271/Pedro Lopez, Dennis R Taaffe, Robert U Newton...
https://pubmed.ncbi.nlm.nih.gov/33219369/Mohamed El Hadouchi, Henri Kiers, Cindy Veenhof...
https://pubmed.ncbi.nlm.nih.gov/40547363/Laisa Teleni, Raymond J Chan, Alexandre Chan...
https://pubmed.ncbi.nlm.nih.gov/26584972/Jason R Gardner, Patricia M Livingston, Steve F Fraser
https://pubmed.ncbi.nlm.nih.gov/24344218/Gao Yunfeng, He Weiyang, He Xueyang...
https://pubmed.ncbi.nlm.nih.gov/28682886/Per Aagaard, Erik B Simonsen, Jesper L Andersen...
https://pubmed.ncbi.nlm.nih.gov/12015341/Siyu Tian, Meng Ding, Hongfu Sun
https://pubmed.ncbi.nlm.nih.gov/36382930/Shabnam Ziaee, Gina Chia-Yi Chu, Jen-Ming Huang...
https://pubmed.ncbi.nlm.nih.gov/26816842/Nourhan M Bassyouny, Mohamed M Gouda, Mai M Ezz El Din...
https://pubmed.ncbi.nlm.nih.gov/39398693/University of Alicante
Lead Sponsor
Hospital General Universitario Dr. Balmis de Alicante
Collaborating Sponsor